These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1973719)

  • 81. Peripheral blood T cell activation after radioiodine treatment for Graves' disease.
    Teng WP; Stark R; Munro AJ; Young SM; Borysiewicz LK; Weetman AP
    Acta Endocrinol (Copenh); 1990 Feb; 122(2):233-40. PubMed ID: 2316311
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Regional stimulation of thyroid epithelial cells in Graves' disease by lymphocytic aggregates and plasma cells.
    Paschke R; Brückner N; Eck T; Schaaf L; Back W; Usadel KH
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):459-65. PubMed ID: 1759536
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Amiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset.
    Rabinowe SL; Larsen PR; Antman EM; George KL; Friedman PL; Jackson RA; Eisenbarth GS
    Am J Med; 1986 Jul; 81(1):53-7. PubMed ID: 3487980
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Studies on rat sera immunized with solubilized thyroid microsomal antigen].
    Hirakawa S
    Nihon Naibunpi Gakkai Zasshi; 1983 Jan; 59(1):53-63. PubMed ID: 6339280
    [No Abstract]   [Full Text] [Related]  

  • 85. B- and T-lymphocytes in ocular disease.
    Jakobiec FA; Lefkowitch J; Knowles DM
    Ophthalmology; 1984 Jun; 91(6):635-54. PubMed ID: 6235470
    [TBL] [Abstract][Full Text] [Related]  

  • 86. HLA-DR antigen expression on the thyrocytes of Graves' disease patients.
    Lee MS; Shong YK; Cho BY; Lee HK; Koh CS; Min HK; Lee M; Oh SK; Whang ES; Cha CY
    Korean J Intern Med; 1988 Jan; 3(1):15-23. PubMed ID: 3153790
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Separation and analysis of mononuclear cells infiltrating the thyroid of patients with Graves' disease.
    Aozasa M; Amino N; Iwatani Y; Tamaki H; Tachi J; Fujiyasu S; Nasu M; Matsuzuka F; Kuma K; Miyai K
    Clin Immunol Immunopathol; 1987 Jun; 43(3):343-53. PubMed ID: 3581516
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Predominant intraepithelial localization of primed T cells and immunoglobulin-producing lymphocytes in Graves' disease.
    Paschke R; Brückner N; Schmeidl R; Pfiester P; Usadel KH
    Acta Endocrinol (Copenh); 1991 Jun; 124(6):630-6. PubMed ID: 1829871
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cytokines and immune regulation in thyroid autoimmunity.
    Nagataki S; Eguchi K
    Autoimmunity; 1992; 13(1):27-34. PubMed ID: 1420803
    [TBL] [Abstract][Full Text] [Related]  

  • 90. New thoughts about the cause and treatment of the severe ocular manifestations of Graves' disease.
    McDougall IR; Kriss JP
    Scott Med J; 1974 Jul; 19(4):165-9. PubMed ID: 4601348
    [No Abstract]   [Full Text] [Related]  

  • 91. Reduced intrathyroidal K-cell activity in Graves' disease.
    Bogner U; Schleusener H
    Acta Endocrinol Suppl (Copenh); 1987; 281():96-8. PubMed ID: 3475925
    [No Abstract]   [Full Text] [Related]  

  • 92. Lower proportion of intra-thyroidal B lymphocytes CD20
    Barros Silva AC; Damas II; Moma CA; Barreto IS; Zantut-Wittmann DE
    Mol Cell Endocrinol; 2024 Jul; 592():112331. PubMed ID: 39029780
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Circulating immune complexes in Graves' disease.
    Cano PO; Chertman MM; Jerry LM; McKenzie JM
    Endocr Res Commun; 1976; 3(5):307-17. PubMed ID: 1036482
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Lymphocyte subpopulations in Graves' ophthalmopathy.
    Felberg NT; Sergott RC; Savino PJ; Blizzard JJ; Schatz NJ; Amsel J
    Arch Ophthalmol; 1985 May; 103(5):656-9. PubMed ID: 3873236
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Islet cell surface antibodies in Graves' disease; as organ non-specific antibodies.
    Ahn IM; Izumi M; Nagataki S
    Korean J Intern Med; 1988 Jan; 3(1):38-44. PubMed ID: 3153792
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [T- and B-lymphocytes in peripheral blood of children and adolescents with Graves' disease].
    Rybakowa M; Mytar B; Sołtysik-Wilk E; Pleti M; Mizerski J
    Endokrynol Pol; 1979; 30(4):361-6. PubMed ID: 315308
    [No Abstract]   [Full Text] [Related]  

  • 97. mRNA-Seq reveals novel molecular mechanisms and a robust fingerprint in Graves' disease.
    Yin X; Sachidanandam R; Morshed S; Latif R; Shi R; Davies TF
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2076-83. PubMed ID: 24971664
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cytokines and Graves' disease.
    Weetman AP; Ajjan RA; Watson PF
    Baillieres Clin Endocrinol Metab; 1997 Oct; 11(3):481-97. PubMed ID: 9532335
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Immunoelectron microscopic studies on the cell surface location of the thyroid microsomal antigen.
    Nilsson M; Mölne J; Karlsson FA; Ericson LE
    Mol Cell Endocrinol; 1987 Oct; 53(3):177-86. PubMed ID: 3666297
    [TBL] [Abstract][Full Text] [Related]  

  • 100. New insights into thyroid physiology.
    JAMA; 1978 Oct; 240(17):1833-4. PubMed ID: 581202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.